Case Report: Management of cervical intramedullary spinal cord metastasis from NSCLC with a literature review
Authors:
Open Access
- 25 February 2026
- journal article
- case report
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 13, 1760091
Abstract
Background: Intramedullary spinal cord metastases (ISCM) from non-small cell lung cancer (NSCLC) are rare and carry a grave prognosis. Cervical segment involvement is exceptionally uncommon, and its distinct clinicopathological profile is not well characterized. Methods: We present the case of a 72-year-old male with a history of NSCLC who developed acute quadriparesis and sphincter dysfunction. Cervical magnetic resonance imaging (MRI) revealed a C7 intramedullary mass. The patient underwent C6-T1 laminectomy with microsurgical gross-total resection. Histopathology confirmed metastatic lung adenocarcinoma. We supplemented this case with a systematic literature review of NSCLC-derived ISCM cases to summarize demographic, clinical, and therapeutic outcomes. Results: Histopathology confirmed metastatic lung adenocarcinoma. Postoperatively, the patient's neurological function improved. Although local recurrence was detected at 11 months and treated with salvage radiotherapy, the patient nevertheless maintained ambulatory function and was alive at the 18-month follow-up. Our literature review of 68 cases with complete data identified a male predominance (4.2:1 ratio) and a mean age of 58.1 years. The cervical spine was the most commonly involved segment (47.1%). Analysis of treatment modalities revealed that multimodal therapy, particularly the combination of surgery and chemotherapy (potentially incorporating modern agents such as immune checkpoint inhibitors), was associated with improved survival, with a mean overall survival of 15.0 months in this subgroup. This paradigm, centered around maximal safe resection, successfully achieved long-term functional preservation and survival. Conclusion: Cervical ISCM from NSCLC represents one of the most challenging complications in spinal oncology. This case, supported by our literature review, provides a surgical-led, multimodal management template for spine surgeons, demonstrating that aggressive yet strategic intervention can achieve favorable long-term neurological and survival outcomes.Keywords
This publication has 38 references indexed in Scilit:
- A case of sustained neurological improvement in a metastatic intramedullary spinal cord tumor from lung cancer treated with immune checkpoint inhibitor therapyEuropean Spine Journal, 2025
- Survival and neurological outcomes following management of intramedullary spinal metastasis patients: a case series with comprehensive review of the literatureNeurosurgical Review, 2024
- Surgical treatment of intramedullary spinal cord metastases: functional outcome and complications—a multicenter studyNeurosurgical Review, 2021
- The Central Dot SignClinical Neuroradiology, 2020
- Intramedullary spinal cord metastases: an institutional review of survival and outcomesJournal of Neuro-Oncology, 2019
- Multimodality therapy improves survival in intramedullary spinal cord metastasis of lung primaryHematology/Oncology and Stem Cell Therapy, 2017
- Retrospective study of 19 patients with intramedullary spinal cord metastasisClinical Neurology and Neurosurgery, 2009
- Clinical outcome in patients with intramedullary spinal cord metastases from lung cancerClinical and Translational Oncology, 2007
- Intramedullary spinal cord metastases: diagnosis and treatment – an illustrated reviewActa Neurochirurgica, 2004
- MRI diagnosis of intramedullary metastases from extra-CNS tumorsEuropean Radiology, 1997